A narrative review synthesizing observational studies, case reports, and small cohorts on pembrolizumab cardiotoxicity; no systematic protocol, single-author selection, and reliance on emerging evidence from small studies limit strength.
A structured narrative review synthesizing evidence from RCTs, meta-analyses, and mechanistic studies to establish a conceptual framework and therapeutic recommendations for SGLT2 inhibitor use across cardiovascular-renal-metabolic conditions.